Octopamine receptors in the honeybee (Apis mellifera) brain and their disruption by RNA-mediated interference
Introduction
Octopamine is a multifunctional naturally occurring biogenic amine that plays a major neuromodulatory role in invertebrates (David and Coulon, 1985). Octopamine modulates nonassociative learning, such as food-induced arousal (Braun and Bicker, 1992) and responses to conditioned olfactory stimuli (Mercer and Menzel, 1982, Hildebrandt and Müller, 1994). It enhances associative olfactory memory consolidation when injected to mushroom bodies (MB) or antennal lobes (AL) (Hammer and Menzel, 1998). Collective evidence suggests that octopamine plays an important role in olfactory learning and memory processes in the honeybee brain.
In the honeybee, an octopaminergic neuron (VUMmx1) mediates an interaction between an odor-sensitive (CS) and sucrose-sensitive (US) pathways in the AL (Hammer, 1993). The convergence of these two types of stimuli suggests that the AL is a site where at least a component of olfactory memory consolidates (Farooqui et al., 2003). VUMmx1 responds to odor only after pairing that odor with an unconditioned stimulus (sucrose). VUMmx1 releases octopamine into all or most glomeruli of the AL (Hammer, 1993). Its responsiveness to odor changes in a way correlated to associative changes in the behavioral response to odor in the conditioning paradigm (Hammer, 1993).
Multiple octopamine receptor subtypes have been pharmacologically characterized in locust nervous tissue (Evans and Robb, 1993, Roeder and Nathanson, 1993, Howell and Evans, 1998). Based on these studies at least two different types of octopamine receptors exist in the insect CNS: (1) OCTOPAMINE1 receptor inhibits myogenic rhythm through an increase in calcium levels and (2) OCTOPAMINE2 receptor modulates neuromuscular transmission by increasing the level of adenylate cyclase activity (Evans, 1993).
Recently, molecular cloning has identified two octopamine receptors in fruitfly. One of them was designated as a tyramine/octopamine receptor which has higher affinity for tyramine than octopamine in inhibiting adenylyl cyclase activity (Robb et al., 1994). Another octopamine receptor was designated as OAMB, which is highly expressed in the MB of the brain and has higher efficacy for octopamine than tyramine in activating cAMP accumulation (Han et al., 1998). Two alternatively spliced forms of octopamine receptor sequences have also been published from fruitfly (NCBI accession no: splice variant 1A, AJ007618; splice variant 1B, AJ007617).
An octopamine receptor from honeybee brain (AmOA11) has been recently isolated and characterized (Grohmann et al., 20031). AmOA1 encodes a protein most closely related to octopamine receptors from Drosophila melanogaster and Lymnea stagnalis. The AmOA1 gene is abundantly expressed in many somata of the honeybee brain, which suggests its involvement in the processing of sensory inputs, antennal motor outputs and high-order brain functions. Furthermore, its expression in the cells of the MB, AL, and optic lobes (OL) suggests its involvement in the processing of olfactory and visual information (Grohmann et al., 2003).
We have previously reported disruption of AmOA1 in the AL of the honeybee brain by blocking the receptor with mianserin and silencing specific gene expression by RNAi (Farooqui et al., 2003). Application of AmOA1–dsRNA in the AL produced 40% reduction in receptor (~78 kDa) protein expression in dsRNA-treated subjects (Farooqui et al., 2003). Both treatments inhibited olfactory acquisition and recall but did not affect odor discrimination. Thus, octopamine mediates consolidation of a component of olfactory memory at this early processing stage in the AL. Furthermore, after consolidation OA release becomes essential for recall, suggesting that the modulatory circuits become incorporated as essential components of neural representations that activate odor memory (Farooqui et al., 2003).
Our current results extend our earlier study by showing that our anti-AmOA1 antiserum recognizes four protein bands (48, 60, 72, and 78 kDa) in the brain. The 78 kDa band, which we reported earlier (Farooqui et al., 2003), as well as another smaller band (72 kDa) are the only ones expressed in the AL. The intensity of all four bands is reduced by AmOA1–dsRNA, and this reduction is a function of time and distance from a localized site of dsRNA treatment in the AL.
Section snippets
Subjects
Subjects used for this study were honeybees (Apis mellifera). They were from queens that were bred from a controlled breeding population maintained at The Rothenbuhler Honey Bee Research Laboratory at The Ohio State University.
Brain dissection
Honeybee brains were dissected in ice-cold honeybee saline (135 mM NaCl, 5.3 mM KCl, 1.36 mM CaCl2, 8.47 mM sucrose, 50 mM Trizma HCl, pH 7.0). The hypopharyngeal glands and the retinal pigment from each bee were removed. Four dissected brains were homogenized in 150 μl
Deduced amino acid sequence and structural properties of octopamine receptor
Grohmann et al. (2003) have published a complete amino acid sequence of AmOA1 from honeybee brain (NCBI accession no: AmOA1, AJ547798). The partial segment of a honeybee brain octopamine receptor that we reported earlier as AmOAR (NCBI accession no: AmOAR, AY263366) is 100% identical to AmOA1 in its amino acid and nucleotide sequence, which suggests that it is the same receptor.
In the studies reported below, we employed anti-AmOAR antiserum and dsRNA construct used previously (Farooqui et al.,
Discussion
In the present study, we have identified four protein bands in the honeybee brain, which are recognized by two specific octopamine receptor antisera: one was raised against a peptide selected from an intracellular region (IL4) of AmOA1 sequence (Farooqui et al., 2003), and the second was raised against another peptide selected from an intracellular region (IL3) of OAMB sequence (Han et al., 1998). Furthermore, the expression of all of these proteins is reduced by AmOA1 dsRNA treatment, which
Acknowledgements
We thank Kyung-An Han, for providing OAMB antiserum for the study. This research was supported by: NIH Grant 9 R01RR14166 from NCRR to B.H.S.
References (49)
- et al.
Octopamine in vertebrates and invertebrates, a review
Progress in Neurobiology
(1985) - et al.
Synergy between tumor necrosis factor a and interleukin 1b in inducing transcriptional down-regulation of muscarinic M2 receptor gene expression
Journal of Biological Chemistry
(1996) - et al.
DAMB, a novel dopamine receptor expressed specifically in Drosophila mushroom bodies
Neuron
(1996) - et al.
Alternative splicing of a Drosophila GABA receptor subunit gene identifies determinants of agonist potency
Neuroscience
(2001) - et al.
Use of dsRNA-mediated genetic interference to demonstrate that frizzled and frizzled 2 act in the wingless pathway
Cell
(1998) - et al.
Isolation and N-terminal amino acid sequence of an octopamine ligand binding protein
FEBS Letters
(1989) - et al.
A primordial dopamine D1-like adenylyl cyclase-linked receptor from Drosophila melanogaster displaying poor affinity for benzazepines
FEBS Letters
(1995) - et al.
Cloning of biogenic amine receptors from moths (Bombyx mori and Heliothis virescens)
Insect Biochemistry and Molecular Biology
(1996) - et al.
Evidence that processed small dsRNAs may mediate sequence specific mRNA degradation during RNAi in Drosophila embryos
Current Biology
(2000) - et al.
RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals
Cell
(2000)